Scott Brydon
About Scott Brydon
Scott Brydon is the Immuno-Oncology Lifecycle Manager at Bristol-Myers Squibb in Melbourne, Australia, with extensive experience in pharmaceutical marketing, market access, and healthcare innovation.
Title
Scott Brydon is currently an Immuno-Oncology Lifecycle Manager at Bristol-Myers Squibb in Melbourne, Australia.
Career at Bristol-Myers Squibb
Scott Brydon initially joined Bristol-Myers Squibb as a Market Access Manager from 2010 to 2015, where he worked for 5 years in Melbourne, Australia. He later transitioned to his current role as Immuno-Oncology Lifecycle Manager, where he leads the definition, design, execution, and measurement of Australian brand strategy for immuno-oncology agents. He manages marketing aspects of BMS immuno-oncology assets 24-12 months prior to launch and provides cross-functional leadership to develop innovative marketing strategies.
Previous Work Experience
Before his tenure at Bristol-Myers Squibb, Scott Brydon worked as a Schedule Analyst at Pharmac from 2008 to 2011 for 3 years. He also served briefly as a Dispensary Manager at Koroit Pharmacy in 2008 for 2 months. Additionally, he worked at Unichem Pharmacy as a Pharmacist until 2008. Earlier, he gained experience through summer studentships at the University of Otago from 2004 to 2005.
Education and Expertise
Scott Brydon holds a Master of Business Administration (MBA) from the University of Melbourne - Melbourne Business School, earned from 2012 to 2014. He also has a Graduate Diploma in Health Economics and Policy from Monash University, achieved from 2008 to 2010. He completed his Bachelor of Pharmacy (BPharm) at the University of Otago, where he studied from 2003 to 2006.
Specializations and Interests
Scott Brydon specializes in market access, launch effectiveness marketing, government liaison, negotiation, patient/healthcare professional liaison, and financial and feasibility analysis. He has a strong interest in pharmaceutical marketing, particularly in launch effectiveness and market access opportunities within Australia. He is passionate about delivering healthcare innovation and designing effective product commercialization strategies for oncology new product launches.